Literature DB >> 8346217

Interleukin 1 induction of the c-jun promoter.

K Muegge1, M Vila, G L Gusella, T Musso, P Herrlich, B Stein, S K Durum.   

Abstract

Interleukin 1 (IL-1) induces pleiotropic effects in many cell types during inflammation and immunity. We have recently shown how the IL-1 signal is transmitted to the nucleus: In T cells and in pituitary cells, IL-1 induced genes via activation of the nuclear factor AP-1. We now demonstrate how IL-1 activates the AP-1 factor in liver cells, which are a major target for IL-1 during the acute phase response in vivo. IL-1 induced gene transcription of both AP-1 components, c-jun and c-fos. IL-1 also increased the stability of c-jun mRNA. We define two enhancer sites in the jun promoter that are required for induction by IL-1. Although the binding sites share some similarity with the AP-1 binding site, the nuclear factors binding the jun motifs are not composed of Jun or Fos proteins. Thus these data identify two binding proteins that serve as one of the first nuclear targets for IL-1 signal transduction.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8346217      PMCID: PMC47074          DOI: 10.1073/pnas.90.15.7054

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  12-O-tetradecanoyl-phorbol-13-acetate induction of the human collagenase gene is mediated by an inducible enhancer element located in the 5'-flanking region.

Authors:  P Angel; I Baumann; B Stein; H Delius; H J Rahmsdorf; P Herrlich
Journal:  Mol Cell Biol       Date:  1987-06       Impact factor: 4.272

Review 2.  Fos and Jun: the AP-1 connection.

Authors:  T Curran; B R Franza
Journal:  Cell       Date:  1988-11-04       Impact factor: 41.582

3.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1.

Authors:  P Angel; K Hattori; T Smeal; M Karin
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

4.  cDNA expression cloning of the IL-1 receptor, a member of the immunoglobulin superfamily.

Authors:  J E Sims; C J March; D Cosman; M B Widmer; H R MacDonald; C J McMahan; C E Grubin; J M Wignall; J L Jackson; S M Call
Journal:  Science       Date:  1988-07-29       Impact factor: 47.728

5.  Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha.

Authors:  D A Brenner; M O'Hara; P Angel; M Chojkier; M Karin
Journal:  Nature       Date:  1989-02-16       Impact factor: 49.962

6.  Interleukin 1 and cyclic AMP induce kappa immunoglobulin light-chain expression via activation of an NF-kappa B-like DNA-binding protein.

Authors:  F Shirakawa; M Chedid; J Suttles; B A Pollok; S B Mizel
Journal:  Mol Cell Biol       Date:  1989-03       Impact factor: 4.272

7.  Jun-B differs in its biological properties from, and is a negative regulator of, c-Jun.

Authors:  R Chiu; P Angel; M Karin
Journal:  Cell       Date:  1989-12-22       Impact factor: 41.582

8.  Mapping of epidermal growth factor-, serum-, and phorbol ester-responsive sequence elements in the c-jun promoter.

Authors:  T H Han; W W Lamph; R Prywes
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

9.  A quantitative method for analyzing specific DNA sequences directly from whole cells.

Authors:  P McIntyre; G R Stark
Journal:  Anal Biochem       Date:  1988-10       Impact factor: 3.365

10.  Interleukin-1 costimulatory activity on the interleukin-2 promoter via AP-1.

Authors:  K Muegge; T M Williams; J Kant; M Karin; R Chiu; A Schmidt; U Siebenlist; H A Young; S K Durum
Journal:  Science       Date:  1989-10-13       Impact factor: 47.728

View more
  15 in total

1.  Oxidant-induced activation of nuclear factor-kappa B in cultured guinea pig gastric epithelial cells.

Authors:  K Rokutan; S Teshima; M Miyoshi; T Nikawa; K Kishi
Journal:  Dig Dis Sci       Date:  1997-09       Impact factor: 3.199

Review 2.  The role of interleukin-1 in the failing heart.

Authors:  C S Long
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

3.  Amino acids control mammalian gene transcription: activating transcription factor 2 is essential for the amino acid responsiveness of the CHOP promoter.

Authors:  A Bruhat; C Jousse; V Carraro; A M Reimold; M Ferrara; P Fafournoux
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

4.  Smad3-Smad4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor beta.

Authors:  C Wong; E M Rougier-Chapman; J P Frederick; M B Datto; N T Liberati; J M Li; X F Wang
Journal:  Mol Cell Biol       Date:  1999-03       Impact factor: 4.272

5.  Signal transduction by tumor necrosis factor mediated by JNK protein kinases.

Authors:  H K Sluss; T Barrett; B Dérijard; R J Davis
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

6.  IL-1beta-driven ST2L expression promotes maturation resistance in rapamycin-conditioned dendritic cells.

Authors:  Heth R Turnquist; Tina L Sumpter; Allan Tsung; Alan F Zahorchak; Atsunori Nakao; Gerard J Nau; Foo Y Liew; David A Geller; Angus W Thomson
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

7.  Expression profile of human gingival fibroblasts induced by interleukin-1beta reveals central role of nuclear factor-kappa B in stabilizing human gingival fibroblasts during inflammation.

Authors:  Saynur Vardar-Sengul; Shilpi Arora; Haluk Baylas; Dan Mercola
Journal:  J Periodontol       Date:  2009-05       Impact factor: 6.993

8.  Phosphorylation of ATF2 and interaction with NFY induces c-Jun in the gonadotrope.

Authors:  Lacey L Lindaman; Debra M Yeh; Changchuan Xie; Kellie M Breen; Djurdjica Coss
Journal:  Mol Cell Endocrinol       Date:  2012-11-20       Impact factor: 4.102

9.  Osmotic regulation of cytokine synthesis in vitro.

Authors:  L Shapiro; C A Dinarello
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

10.  ATF-2 contains a phosphorylation-dependent transcriptional activation domain.

Authors:  C Livingstone; G Patel; N Jones
Journal:  EMBO J       Date:  1995-04-18       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.